Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intanwijaya Internasional Tbk (INCI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Intanwijaya Internasional TbkTrade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Intanwijaya Internasional Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Intanwijaya Internasional Tbk trades at Rp645 (market cap 133.94B, 13.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 83.5× Intanwijaya Internasional Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 13.9K). Which is the better fit depends on your goals.

INCITSPC
Market Cap
133.94B11.18T
Volume
13.9K613K
Lot
1396.13K
Turnover
8.97M1.54B
Average Price
6452,511.52
Value
8.97M1.54B
Indicative Equilibrium Price
2,520
Indicative Equilibrium Volume
17

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INCI
View details
TSPC
View details

About Intanwijaya Internasional Tbk

PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.

Read more on INCI

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC